SEC Form 4 · accession 0001192482-17-000263
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alison B Fleming
Officer — Chief Technology Officer
Period of report
Oct 25, 2017
Accepted (ET)
Oct 27, 2017 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 25, 2017 | M | 1,811 | $3.38 | A | 26,563 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to purchase)F1 | $3.38 | Oct 25, 2017 | M | 1,811 | D | — | Nov 1, 2017 | Common Stock | 1,811 | 0 | D |
Explanation of responses
- F1All of these options were fully vested and excercisable as of October 25, 2017.